Resources for Food and Drug Administration (FDA)

FDA Fast-Tracks Sabril as Anti-Craving Drug

alcoholism.about.com

The U.S. Food and Drug Administration has placed the drug vigabatrin, to be marketed under the name Sabril, on a fast track for approval for the treatment of cocaine and methamphetamine addiction. The drug is already approved as an anticonvulsant used for the treatment of seizures and infantile spasms.

Sabril works for cocaine and meth users by reducing the cravings for the drugs. If they do use meth or cocaine, Sabril blocks the euphoria usually experienced with their use, according to Ovation Pharmaceuticals, manufacturer of the drug.

View the Resource

Share or bookmarklet this web page at: